Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);骨形态发生蛋白受体(Bone Morphogenetic Protein Receptors);骨形态发生蛋白质类(Bone Morphogenetic Proteins);细胞增殖(Cell Proliferation);顺铂(Cisplatin);无病生存(Disease-Free Survival);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);卵巢肿瘤(Ovarian Neoplasms);吡唑类(Pyrazoles);喹啉类(Quinolines);信号传导(Signal Transduction);球形体, 细胞(Spheroids, Cellular);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1016/j.canlet.2015.07.032
PMID
26235139
发布时间
2021-10-20
- 浏览47

Cancer letters
79-87页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文